Incannex Healthcare Files 8-K on Shareholder Vote Matters
Ticker: IXHL · Form: 8-K · Filed: Dec 11, 2024 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Dec 11, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
INCANNEX HELD SHAREHOLDER VOTE - DETAILS TO FOLLOW.
AI Summary
Incannex Healthcare Inc. filed an 8-K on December 11, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the vote's outcome or the proposals presented, but it formally documents the event as required by the SEC.
Why It Matters
This filing indicates that Incannex Healthcare Inc. has held or is holding a shareholder meeting where important decisions were or will be made, which could impact the company's future direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial or operational risks.
Key Players & Entities
- Incannex Healthcare Inc. (company) — Registrant
- December 11, 2024 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of Incannex Healthcare Inc.'s security holders?
The filing does not specify the exact proposals or matters that were submitted to a vote of security holders.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on December 11, 2024.
What is the principal executive office address for Incannex Healthcare Inc. as listed in the filing?
The address of the Principal Executive Offices is Suite 105, 8 Century Circuit Norwest, NSW 2153 Australia.
What is the SEC file number for Incannex Healthcare Inc.?
The SEC file number for Incannex Healthcare Inc. is 001-41106.
What is the Standard Industrial Classification code for Incannex Healthcare Inc.?
The Standard Industrial Classification code for Incannex Healthcare Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 792 words · 3 min read · ~3 pages · Grade level 14.9 · Accepted 2024-12-11 16:04:53
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
Filing Documents
- ea0224308-8k_incannex.htm (8-K) — 37KB
- 0001213900-24-107879.txt ( ) — 209KB
- ixhl-20241211.xsd (EX-101.SCH) — 3KB
- ixhl-20241211_lab.xml (EX-101.LAB) — 33KB
- ixhl-20241211_pre.xml (EX-101.PRE) — 22KB
- ea0224308-8k_incannex_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: December 11, 2024 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2